Table 1.
Baseline characteristics of the study population.
| Baseline Characteristics | N (%) |
|---|---|
| Sex | |
| Male | 126 (83.4) |
| Female | 25 (16.6) |
| Mean Age (Years) | 55.1 |
| Male | 55.5 |
| Female | 58.5 |
| Diabetic | 56 (37.1) |
| Hypertensive | 62 (41.1) |
| Smoker | 82 (54.3) |
| Tobacco Chewer | 19 (12.6) |
| Dyslipidemia | 110 (72.8) |
| Positive Family History | 15 (9.9) |
| Chronic Stable Angina | 40 (26.5) |
| Past History of ACS Present | 21 (52.5) |
| Past History of PCI Present (Elective/Emergency) | 18 (45) |
| Acute Coronary Syndrome | 111 (73.5) |
| STEMI | 97 (87.4) |
| NSTEMI | 10 (9.0) |
| UA | 4 (3.6) |
| Post PCI [ Primary/Early (for NSTEMI or UA)] | 94 (84.7) |
| Medicine Pattern | |
| Antiplatelets | 151 (100) |
| Aspirin | 151 (100) |
| Clopidogrel | 144 (95.4) |
| DAPT (Aspirin + Clopidogrel) | 144 (95.4) |
| ACEI or ARB | 142 (94) |
| Beta-blockers | 128 (84.8) |
| Nitrates | 110 (72.8) |
| Statins | 151 (100) |
| Diuretics | 40 (26.5) |
| Spironolactone | 33 (21.8) |
ACS= Acute coronary syndrome, PCI= Percutaneous coronary intervention, Non-ST segment elevation myocardial ischemia, UA= Unstable angina, DAPT = Dual antiplatelet, ACEI = Angiotensin converting enzyme inhibitor, ARB = Angiotensin receptor blocker.